LEO Pharma - Crunchbase Company Profile & Funding

Q: Where is LEO Pharma's headquarters?

LEO Pharma is located in Ballerup, Hovedstaden, Denmark.

Q: Who invested in LEO Pharma?

LEO Pharma is funded by Nordic Capital.

Q: When was the last funding round for LEO Pharma?

LEO Pharma closed its last funding round on obfuscated from a Private Equity round.

Q: How much funding has LEO Pharma raised to date?

LEO Pharma has raised obfuscated.

Overview

LEO Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About LEO Pharma

CB Rank

9656

LEO Pharma is a pharmaceutical company that specializes in medical dermatology.

Founded

obfuscation

Private

Private Equity

Ballerup, Hovedstaden, Denmark

1001-5000

www.leo-pharma.com

Biotechnology

Health Care

Manufacturing

Pharmaceutical

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Julie Serritslev: Director, Global Program Leader, R&D Portfolio and Program Leadership
Past Role: Hue-ga, Co-founder
Anders Kronborg: CFO
Past Role: Kinnevik, Investment Director

Details

Legal Name

LEO Pharma A/S

Operating Status

Active

Company Type

For Profit

Founders

Anton Antons, August Kongsted

About the Company

LEO Pharma is a pharma company that specializes in medical dermatology. They support people in managing their skin conditions. They provide research and development to deliver products and solutions.

Phone Number

+45 4494 5888

Contact Email

info.dk@leo-pharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

LEO Pharma is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Anzupgo®

A topical treatment for chronic hand eczema designed to manage symptoms and improve skin condition.

Delgocitinib Cream

A topical cream under clinical trial for treating mild to severe palmoplantar pustulosis (PPP).

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity
obfuscated obfuscation	Private Equity Round - LEO Pharma	1	obfuscated obfuscation	Nordic Capital	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Nordic Capital	Yes	Private Equity Round - LEO Pharma	Jonas Agnblad
Nordic Capital	Yes	Private Equity Round - LEO Pharma	Jonas Agnblad
Nordic Capital	Yes	Private Equity Round - LEO Pharma	Jonas Agnblad
Nordic Capital	Yes	Private Equity Round - LEO Pharma	Jonas Agnblad
Nordic Capital	Yes	Private Equity Round - LEO Pharma	Jonas Agnblad

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

Market Intelligence

People

View Profiles & Contacts

Headcount

1001-5000

Employee Profiles

Board Members and Advisors

Contacts

762

Employee Profiles

Julie Serritslev Director, Global Program Leader, R&D Portfolio and Program Leadership
Anders Kronborg CFO
Tiffany Christian Vice President, US Legal & Compliance
Brian Hilberdink Executive Vice President and President